PMC Articles for MedGen (Select 389224) - PMC

Links from MedGen

Items: 1 to 20 of 124

<< First< Prev

Page of 7

Select item 94909431.

Effect of the combination of bumetanide plus chlorthalidone on hypertension and volume overload in patients with chronic kidney disease stage 4–5 KDIGO without renal replacement therapy: a double-blind randomized HEBE-CKD trial

Fabio Solis-Jimenez, Lucia Monserrat Perez-Navarro, Ricardo Cabrera-Barron, Jesus Antonio Chida-Romero, Geovana Martin-Alemañy, Edgar Dehesa-López, Magdalena Madero, Rafael Valdez-Ortiz

BMC Nephrol. 2022; 23: 316. Published online 2022 Sep 20. doi: 10.1186/s12882-022-02930-4

PMCID:: PMC9490943

Abstract Article PDF–1.7M

Select item 60240282.

A case report of remission of refractory membranous nephropathy progressing to stage 4 chronic kidney disease using low-dose rituximab: A long-term follow-up

Xu-Jie Zhou, Fu-De Zhou, Su-Xia Wang, Ming-Hui Zhao

Medicine (Baltimore) 2018 Jun; 97(25): e11184. Published online 2018 Jun 22. doi: 10.1097/MD.0000000000011184

PMCID:: PMC6024028

Abstract Article PDF–577K

Select item 61382393.

Pharmacokinetics of metformin in patients with chronic kidney disease stage 4 and metformin‐naïve type 2 diabetes

Ajith M. Dissanayake, Mark C. Wheldon, Christopher J. Hood

Pharmacol Res Perspect. 2018 Oct; 6(5): e00424. Published online 2018 Sep 14. doi: 10.1002/prp2.424

PMCID:: PMC6138239

Abstract Article PDF–2.1M

Select item 64114734.

Nephrology consultation and mortality in people with stage 4 chronic kidney disease: a population-based study

Ping Liu, Robert R. Quinn, Mohammad Ehsanul Karim, Aminu Bello, Helen Tam-Tham, Robert Weaver, Paul E. Ronksley, Hude Quan, Giovanni F.M. Strippoli, Braden Manns, Brenda R. Hemmelgarn, Marcello Tonelli, Pietro Ravani

CMAJ. 2019 Mar 11; 191(10): E274–E282. doi: 10.1503/cmaj.181372

PMCID:: PMC6411473

Abstract Article PDF–301K

Select item 66142555.

Primary Failure of the Arteriovenous Fistula in Patients with Chronic Kidney Disease Stage 4/5

Nikola Gjorgjievski, Pavlina Dzekova-Vidimliski, Vesna Gerasimovska, Svetlana Pavleska-Kuzmanovska, Julija Gjorgievska, Petar Dejanov, Aleksandar Sikole, Ninoslav Ivanovski

Open Access Maced J Med Sci. 2019 Jun 15; 7(11): 1782–1787. Published online 2019 Jun 15. doi: 10.3889/oamjms.2019.541

PMCID:: PMC6614255

Abstract Article PDF–538K

Select item 66250586.

Can billing codes accurately identify rapidly progressing stage 3 and stage 4 chronic kidney disease patients: a diagnostic test study

Kabir Jalal, Edwin J. Anand, Rocco Venuto, Joe Eberle, Pradeep Arora

BMC Nephrol. 2019; 20: 260. Published online 2019 Jul 12. doi: 10.1186/s12882-019-1429-4

PMCID:: PMC6625058

Abstract Article PDF–1.0M

Select item 68726107.

Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysis

André Nanny Vieira Le Sueur, Silvano Salgueiro Geraldes, Alessandra Melchert, Regina Kiomi Takahira, Michael Coyne, Rachel Murphy, Donald Szlosek, Priscylla Tatiana Chalfun Guimarães‐Okamoto

J Vet Intern Med. 2019 Nov-Dec; 33(6): 2635–2643. Published online 2019 Sep 12. doi: 10.1111/jvim.15612

PMCID:: PMC6872610

Abstract Article PDF–913K

Select item 69077208.

Switch-over Study with Fast-acting Insulin Aspart Showing Lower Glycemic Variability in Type 2 Diabetics with Stage 4 Chronic Kidney Disease: A Case Series

Sayak Roy, Mridul Bera, Guruprasad Bhattacharya, Maneesha Khalse

Cureus. 2019 Dec; 11(12): e6344. Published online 2019 Dec 11. doi: 10.7759/cureus.6344

PMCID:: PMC6907720

Abstract Article PDF–108K

Select item 78438059.

The Treatment Effectiveness Evaluation for Slowing the Progression of Diabetic Nephropathy During Stage 4 Chronic Kidney Disease

Tianyu Yu, Shimin Jiang, Yue Yang, Jinying Fang, Guming Zou, Hongmei Gao, Li Zhuo, Wenge Li

Diabetes Ther. 2021 Jan; 12(1): 301–312. Published online 2020 Nov 29. doi: 10.1007/s13300-020-00970-3

PMCID:: PMC7843805

Abstract Article PDF–3.8M

Select item 1043746410.

Clinical and Economic Outcomes in Medicare Beneficiaries with Stage 3 or Stage 4 Chronic Kidney Disease and Anemia: The Role of Intravenous Iron Therapy

Tyler Knight, Kellie Ryan, Caroline Schaefer, Lynell D'Sylva, Emily Durden

J Manag Care Pharm. 2010 Oct; 16(8): 10.18553/jmcp.2010.16.8.605. doi: 10.18553/jmcp.2010.16.8.605

PMCID:: PMC10437464

Abstract PDF–359K

Select item 946039711.

Nutritional Status, Body Composition, and Inflammation Profile in Older Patients with Advanced Chronic Kidney Disease Stage 4–5: A Case-Control Study

Mar Ruperto, Guillermina Barril

Nutrients. 2022 Sep; 14(17): 3650. Published online 2022 Sep 3. doi: 10.3390/nu14173650

PMCID:: PMC9460397

Abstract Article PDF–1.1M

Select item 930960412.

Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5

Chen-Hua Liu, Jia-Horng Kao

Hepatol Int. 2022 Oct; 16(5): 1001–1019. Published online 2022 Jul 25. doi: 10.1007/s12072-022-10390-z

PMCID:: PMC9309604

Abstract Article PDF–672K

Select item 794126713.

Bupi Yishen Formula Versus Losartan for Non-Diabetic Stage 4 Chronic Kidney Disease: A Randomized Controlled Trial

Wei Mao, Nizhi Yang, Lei Zhang, Chuang Li, Yifan Wu, Wenwei Ouyang, Peng Xu, Chuan Zou, Chunpeng Pei, Wei Shi, Jihong Zhan, Hongtao Yang, Hongyu Chen, Xiaoqin Wang, Yun Tian, Fang Yuan, Wei Sun, Guoliang Xiong, Ming Chen, Jianguo Guan, Shuifu Tang, Chunyan Zhang, Yuning Liu, Yueyi Deng, Qizhan Lin, Fuhua Lu, Weihong Hong, Aicheng Yang, Jingai Fang, Jiazhen Rao, Lixin Wang, Kun Bao, Feng Lin, Yuan Xu, Zhaoyu Lu, Guobin Su, La Zhang, David W Johnson, Daixin Zhao, Haijing Hou, Lizhe Fu, Xinfeng Guo, Lihong Yang, Xindong Qin, Zehuai Wen, Xusheng Liu

Front Pharmacol. 2020; 11: 627185. Published online 2021 Jan 29. doi: 10.3389/fphar.2020.627185

PMCID:: PMC7941267

Abstract Article PDF–1.3M

Select item 809750114.

Accounting for the Competing Risk of Death to Predict Kidney Failure in Adults With Stage 4 Chronic Kidney Disease

Huda Al-Wahsh, Navdeep Tangri, Rob Quinn, Ping Liu, Thomas Ferguson, MS, Marta Fiocco, Ngan N. Lam, MD, MSc, Marcello Tonelli, Pietro Ravani

JAMA Netw Open. 2021 May; 4(5): e219225. Published online 2021 May 4. doi: 10.1001/jamanetworkopen.2021.9225

PMCID:: PMC8097501

Abstract Article

Select item 848331215.

Dental health assessed using panoramic radiograph and adverse events in chronic kidney disease stage 4–5 patients transitioning to dialysis and transplantation–A prospective cohort study

Mikko J. Järvisalo, Viljami Jokihaka, Markus Hakamäki, Roosa Lankinen, Heidi Helin, Niina S. Koivuviita, Tapio Hellman, Kaj Metsärinne

PLoS One. 2021; 16(9): e0258055. Published online 2021 Sep 30. doi: 10.1371/journal.pone.0258055

PMCID:: PMC8483312

Abstract Article PDF–678K

Select item 852402916.

Use of Gemcitabine Plus Carboplatin Is Associated with Poor Outcomes in Urothelial Carcinoma Patients with Chronic Kidney Disease Stage 4–5

Hyung-Don Kim, Hyeon-Su Im, Jwa Hoon Kim, Hyehyun Jeong, Shin Kyo Yoon, Inkeun Park, Jae Lyun Lee

Cancer Res Treat. 2021 Oct; 53(4): 1166–1173. Published online 2021 Mar 4. doi: 10.4143/crt.2021.091

PMCID:: PMC8524029

Abstract Article PDF–1.7M

Select item 879059617.

A rare case: Vesicoureteral reflux in Indonesian young adult with neurogenic bladder and chronic kidney disease stage 4

Ardityo Rahmat Ardhany, Satriyo Dwi Suryantoro, Mochammad Thaha, Djoko Santoso

Ann Med Surg (Lond) 2022 Feb; 74: 103267. Published online 2022 Jan 18. doi: 10.1016/j.amsu.2022.103267

PMCID:: PMC8790596

Abstract Article PDF–2.5M

Select item 872983518.

Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease

Glenn M. Chertow, Priya Vart, Niels Jongs, Robert D. Toto, Jose Luis Gorriz, Fan Fan Hou, John J.V. McMurray, Ricardo Correa-Rotter, Peter Rossing, C. David Sjöström, Bergur V. Stefánsson, Anna Maria Langkilde, David C. Wheeler, Hiddo J.L. Heerspink, DAPA-CKD Trial Committees and Investigators

J Am Soc Nephrol. 2021 Sep; 32(9): 2352–2361. Published online 2021 Sep. doi: 10.1681/ASN.2021020167

PMCID:: PMC8729835

Abstract Article

Select item 374197119.

Efficacy and safety of oral doxercalciferol in the management of secondary hyperparathyroidism in chronic kidney disease stage 4

P. C. Dheerendra, V. Sakhuja, H. S. Kohli, V. Jha

Indian J Nephrol. 2013 Jul-Aug; 23(4): 271–275. doi: 10.4103/0971-4065.114492

PMCID:: PMC3741971

Abstract Article PDF–607K

Select item 239098820.

Short-Term Treatment with Sevelamer Increases Serum Fetuin-A Concentration and Improves Endothelial Dysfunction in Chronic Kidney Disease Stage 4 Patients

Kayser Caglar, Mahmut Ilker Yilmaz, Mutlu Saglam, Erdinc Cakir, Cengizhan Acikel, Tayfun Eyileten, Mujdat Yenicesu, Yusuf Oguz, Abdulgaffar Vural, Juan Jesus Carrero, Jonas Axelsson, Bengt Lindholm, Peter Stenvinkel

Clin J Am Soc Nephrol. 2008 Jan; 3(1): 61–68. doi: 10.2215/CJN.02810707

PMCID:: PMC2390988

Abstract Article

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from MedGen

Items: 1 to 20 of 124

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity